200780 — BCWorldPharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩51bn
- KR₩130bn
- KR₩75bn
- 49
- 65
- 31
- 45
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS/A | ARS/A | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,456 | 12,561 | 4,503 | 8,058 | 11,166 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16,142 | 14,722 | 15,942 | 17,778 | 19,483 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 33,846 | 43,063 | 37,235 | 43,609 | 48,086 |
Net Property, Plant And Equipment | 121,740 | 125,500 | 132,370 | 130,119 | 125,628 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 162,171 | 176,925 | 179,358 | 183,051 | 184,111 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 41,446 | 56,160 | 55,892 | 84,206 | 92,246 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 76,221 | 92,764 | 97,901 | 103,499 | 102,468 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 85,950 | 84,161 | 81,458 | 79,552 | 81,643 |
Total Liabilities & Shareholders' Equity | 162,171 | 176,925 | 179,358 | 183,051 | 184,111 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |